Pasar al contenido principal

NUEVAS METODOLOGIAS DE RMN PARA ESTUDIAR N-GLICANOS Y GLICOPROTEINAS

PID2019-105237GB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD COMPLUTENSE DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Revealing the specificity of human H1 influenza A viruses to complex N-glycans

  • Canales, Ángeles
  • Sastre, Javier
  • Orduña, José M.
  • Spruit, Cindy M.
  • Pérez-Castells, Javier
  • Domínguez, Gema
  • Bouwman, Kim M.
  • Van der Woude, Roosmarijn
  • Cañada, F. Javier
  • Nycholat, Corwin M.
  • Paulson, James C.
  • Boons, Geert-Jan
  • Jiménez-Barbero, Jesús
  • De Vries, Robert P.
11 p.-5 fig.-1 schem.-1 graph. abst., Influenza virus infection remains a threat to human health since viral hemagglutinins are constantly drifting, escaping infection and vaccine-induced antibody responses. Viral hemagglutinins from different viruses display variability in glycan recognition. In this context, recent H3N2 viruses have specificity for α2,6 sialylated branched N-glycans with at least three N-acetyllactosamine units (tri-LacNAc). In this work, we combined glycan arrays and tissue binding analyses with nuclear magnetic resonance experiments to characterize the glycan specificity of a family of H1 variants, including the one responsible for the 2009 pandemic outbreak. We also analyzed one engineered H6N1 mutant to understand if the preference for tri-LacNAc motifs could be a general trend in human-type receptor-adapted viruses. In addition, we developed a new NMR approach to perform competition experiments between glycans with similar compositions and different lengths. Our results point out that pandemic H1 viruses differ from previous seasonal H1 viruses by a strict preference for a minimum of di-LacNAc structural motifs., R.P.d.V. is a recipient of an ERC Starting grant from the European Commission (802780) and a Beijerinck Premium of the Royal Dutch Academy of Sciences. The glycan array setup was supported by the Netherlands Organization for Scientific Research (NWO, TOP-PUNT 718.015.003 to G.-J.P.H.B.). Dr. Lin Liu (CCRC) and Dr. Margreet A. Wolfert (Utrecht University) developed, printed, and validated the glycan microarray. We would like to thank Nikoloz Nemanichvili for technical assistance. A.C. acknowledges funding from Agencia Estatal de Investigación “Spanish Ministry of Science and Innovation” (MICINN) project PID2019-105237GB-I00. J.P.C. acknowledges funding by the Spanish MICINN, grant no. RTI2018-095588-B-I00 (co-funded by the European Regional Development Fund/European Social Fund, “Investing in your future”). JJB also thanks funding by the European Research Council (RECGLYCANMR, Advanced grant no. 788143), the Agencia Estatal de Investigación (Spain) for grants RTI2018-094751-B-C21 and C22 and PDI2021-1237810B–C21 and C22, and CIBERES, an initiative of the Instituto de Salud Carlos III (ISCIII), Madrid, Spain., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

N′-phenylacetohydrazide derivatives as potent Ebola virus entry inhibitors with an improved pharmacokinetic profile

  • García-Rubia, Alfonso
  • Lasala, Fátima
  • Ginex, Tiziana
  • Morales-Tenorio, Marcos
  • Olal, Catherine
  • Heung, Michelle
  • Oquist Phillips, Mayra Paola
  • Galindo Barreales, Inmaculada
  • Cuesta-Geijo, Miguel Ángel
  • Casasnovas, José María
  • Campillo, Nuria E.
  • Canales, Ángeles
  • Alonso Martí, Covadonga
  • Martínez Gil, Ana
  • Muñoz-Fontela, César
  • Delgado, Rafael
  • Gil, Carmen
19 p.-6 fig.-7 tab.-1 graph. abst., Ebola virus (EBOV) is a single-strand RNA virus belonging to the Filoviridae family, which has been associated to most Ebola virus disease outbreaks to date, including the West African and the North Kivu epidemics between 2013 and 2022. This unprecedented health emergency prompted the search for effective medical countermeasures. Following up on the carbazole hit identified in our previous studies, we synthetized a new series of compounds, which demonstrated to prevent EBOV infection in cells by acting as virus entry inhibitors. The in vitro inhibitory activity was evaluated through the screening against surrogate models based on viral pseudotypes and further confirmed using replicative EBOV. Docking and molecular dynamics simulations joined to saturation transfer difference–nuclear magnetic resonance (STD–NMR) and mutagenesis experiments to elucidate the biological target of the most potent compounds. Finally, in vitro metabolic stability and in vivo pharmacokinetic studies were performed to confirm their therapeutic potential., The project leading to these results has received funding from “la Caixa” Foundation under the project code LCF/PR/HR19/52160012. This research was partially supported through ERA-NET-2021-862605. Cofounded by AEI, Spain (PCI2021-121939 (C.A.), PID2019-105237GB-I00 (A.C.), PID2021-122825OB (C.A.), and PID2021-122223OB-I00 (C.G.)), Instituto de Salud Carlos III (CIBERINFEC and FIS PI2100989), and the European Commission Horizon 2020 Framework Programme (Project VIRUSCAN FETPROACT-2016: 731868 and Project EPIC-CROWN-2 ID: 101046084). This research work was also funded by the European Commission–NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global). M.M.-T holds a predoctoral FPU grant (FPU18/03493) from MICINN, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Evolution of human H3N2 influenza virus receptor specificity has substantially expanded the receptor-binding domain site

  • Thompson, Andrew J.
  • Wu, Nicholas C.
  • Canales, Ángeles
  • Kikuchi, Chika
  • Zhu, Xueyong
  • Fernández de Toro, Beatriz
  • Cañada, F. Javier
  • Worth, Charli
  • Wang, Shengyang
  • McBride, Ryan
  • Peng, Wenjie
  • Nycholat, Corwin M.
  • Jiménez-Barbero, Jesús
  • Wilson, Ian A.
  • Paulson, James C.
32 p.-7 fig., Hemagglutinins (HAs) from human influenza viruses descend from avian progenitors that bind α2-3-linked sialosides and must adapt to glycans with α2-6-linked sialic acids on human airway cells to transmit within the human population. Since their introduction during the 1968 pandemic, H3N2 viruses have evolved over the past five decades to preferentially recognize human α2-6-sialoside receptors that are elongated through addition of poly-LacNAc. We show that more recent H3N2 viruses now make increasingly complex interactions with elongated receptors while continuously selecting for strains maintaining this phenotype. This change in receptor engagement is accompanied by an extension of the traditional receptor-binding site to include residues in key antigenic sites on the surface of HA trimers. These results help explain the propensity for selection of antigenic variants, leading to vaccine mismatching, when H3N2 viruses are propagated in chicken eggs or cells that do not contain such receptors., This work was supported by NIH R01 AI114730, the Kwang Hua Educational Foundation (J.C.P.), in part by NIHNIAID Centers of Excellence for Influenza Research and Response contract 75N93021C00015 (I.A.W., J.C.P.,N.C.W.), the Bill and Melinda Gates Foundation INV-004923 (I.A.W.), the Spanish Ministry of Science and Innovation, AEI grants PID2019-105237GB-I00 (A.C.), PID2021-123781OB-C21 (J.J.B.) and -C22 (F.J.C.) and BES-2016-076340 (B.F.dT.), and CIBERES, an initiative of the Instituto de Salud Carlos III, Madrid, Spain., Peer reviewed